Advanced Enzyme Technologies Limited (ADVENZYMES.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In INR
Sector
Basic Materials
Industry
Chemicals - Specialty
Employees
323
First IPO Date
August 01, 2016
| Name | Title | Pay | Year Born |
| Michael Puls | MD & Head of Research and Development - evoxx technologies GmbH | 0 | N/A |
| Harshad Doshi | Chief Financial Officer & Chief Operating Officer of US Subsidiaries | 0 | N/A |
| Ronak Saraf | Investor Relations Manager | 0 | N/A |
| Martina Doering | MD & Head of Business Development - evoxx technologies GmbH | 0 | N/A |
| Satish Pagar | Plant Manager & Head of Operations - Sinnar | 0 | N/A |
| Sanjay Prakash Basantani | Company Secretary, Head of Legal & Compliance Officer | 0 | N/A |
| Beni Prasad Rauka | Chief Financial Officer | 0 | 1964 |
| Bhaskar Manolkar | General Manager of Human Resources & Administration | 0 | 1959 |
Advanced Enzyme Technologies Limited, headquartered in Thane, India, is a global company engaged in the research, development, manufacturing, and marketing of enzymes and probiotics. Its operations span India, the United States, Asia, and Europe. The company's diverse enzyme offerings cater to human healthcare, animal nutrition, and an extensive range of food processing sectors, including fruit and vegetable, baking, brewing, malting, grain, protein modification, yeast, dairy, and oils/fats processing, as well as various specialty applications. Beyond food-related uses, it also supplies industrial enzymes for non-food industries like textile processing, leather, pulp and paper production, detergents and cleaning aids, biofuels, and biocatalysis. Founded in 1957, the company was previously known as Advanced Biochemicals Limited before changing its name to Advanced Enzyme Technologies Limited in 2005.